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Abstract 
The importance of neuro-immune interactions in both physiological and pathophysiological 
states cannot be understated. As our appreciation for the neuroimmune nature of the brain and 
spinal cord grows, so does our need to extend the spatial and temporal resolution of our 
molecular analysis techniques. Current imaging technologies applied to investigate the 
actions of the neuroimmune system in both health and disease states have been adapted from 
the fields of immunology and neuroscience and are inherently limited by their semi-
quantitative nature, loss of spatial resolution, photobleaching and detection sensitivity. Thus, 
the development of innovative methods which overcome these limitations are crucial for 
imaging and quantifying acute and chronic neuroimmune responses. Therefore, this review 
aims to convey novel and complementary imaging technologies in a form accessible to 
medical scientists engaging in neuroimmune research.  
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What is Neuroinflammation? 
The neuroimmune system is an incredibly diverse and intricate system comprised of 
endogenous (astrocytes, microglia, neurons and oligodendrocytes) and exogenous 
(infiltrating monocytes and T cells) immune-functioning cells and their associated signalling 
factors within the central nervous system (CNS) (table 1) (Hutchinson et al. 2011). These 
immunocompetent cells are pivotal to both the homeostatic and disease states of the brain and 
spinal cord (Grace et al. 2014; Ousman & Kubes 2012). For example, following injury or 
infection, glial and immune cells act to enhance the elimination of pathogens as well as 
facilitate repair via processes ranging from central immune signalling and neurokine events, 
to gross “neuroinflammation”.  
 
Table 1 Cellular targets historically employed to image, detect and “quantify” neuroinflammation 
 
Neuroinflammation occurs along a graded continuum with each insult displaying its own 
unique neuroinflammatory signature. While acute neuropathological insults such as ischemia 
or infection and chronic neurogenically mediated disorders such as hypertension, have robust 
neuroinflammatory responses, sub-inflammatory neuroimmune responses are now also 
recognized to be associated with various psychiatric disorders (Hutchinson & Watkins 2014; 
Najjar et al. 2013; Wu et al. 2012). These sub-inflammatory responses do not function in a 
traditional inflammatory manner. Rather, this response more closely resembles the discrete 
and localised nature of neurotransmission and hence requires a separate terminology of 
neurokine or central immune signalling (Jacobsen et al. 2014; Hutchinson et al. 2011). 


































































For example, the high levels of inflammatory mediators observed during pathological 
neurodegenerative disease states such as Alzheimer’s and Parkinson’s disease cause neuronal 
cell death, which in turn directly effects an individual’s memory, language, and mood ( 
McGeer & McGeer 2010; Rogers et al. 2007). In contrast, although the lower level of 
neurokine and central immune signalling observed during psychiatric disorders such as 
depression do not appear to result in the gross loss of cells, instead they subtly alter neuronal 
function and in turn behaviour (Eyre & Baune 2012). Table 2 highlights the main 
inflammatory, neurokine and central immune signalling mediators implicated in the 
neuroimmune system. 
 
Table 2 Molecular targets historically employed to image, detect and “quantify” neuroinflammation. 
 
Current limitations of viewing and “quantifying” neuroinflammation 
The most recent technological advances to discern the structure and function of CNS cells 
have focused predominantly on neurons. For example, significant methodological 
improvements to viral tracing, development of fluorescent reporter transgenic animals and 
optogenetics measurement techniques have drastically increased our understanding of 
neuronanatomy and have identified many specific functional subgroups of CNS cells. 
However, most of these techniques are unsuitable for imaging neuroimmune cells. Existing 
techniques are unable to address the most pressing issues within the field of 
neuroimmunology such as, understanding the complex organization of multicellular systems, 
the heterogeneity within and between immune cells and how low abundant inflammatory 
proteins (neurokines) alter behaviour. Researchers in the field attempting to address these 
issues are left with traditional technological modalities that are fraught with difficulties. The 


































































signalling due to the low expression levels of inflammatory mediators. This necessitates the 
use of high affinity antibodies with a strong signal and long life span in order to view and 
quantify these cellular responses. 
 
 Antibodies, which are the most common method to visualize antigens, are at the centre of the 
“reproducibility crisis” within biological science. Current estimates suggest approximately 50 
per cent of antibodies are either unreactive towards the purported epitope or cross-react with 
others (Berglund et al. 2008). This problem is amplified by common chemical treatments on 
the collected tissues that are necessary for many immunohistochemical techniques. 
Specifically, the potential binding of antibodies is reduced by detergents that can denature 
proteins and fixatives - required to stabilize fragile tissues in order to survive the harsh 
staining conditions and subsequent washes, can inadvertently mask antigen-binding sites. 
Furthermore, the current fluorophores, such as fluorescein isothiocyanate (FITC), and 
Alexafluors, used to visualize antibody binding, have a limited lifespan and/or spatial 
resolution, quench in the presence of light and often emit in the same spectrum as the 
biological tissue making it difficult to differentiate between background fluorescence 
(autofluorescence) and the signal of the target protein (Figure 1).  
 
Figure 1 The photobleaching effect of traditional fluorophores. Traditional fluorophores are readily 
photobleached during routine microscopy in brain samples (A). Alexfluor488 labelled activated neurons (c-FOS 
protein, green, black arrows) and Alexafluor555 labelled microglia (OX-42 protein, orange, white arrows) in rat 
hypothalamic sections following acute stress shown as maximum intensity projection images derived from 
epifluorescent widefield microscope obtained z-stacks. In a series of five sequential images significant 
photobleaching results in dramatic loss of detail in fluorescent antibody staining. (B) Zoomed image 
demonstrating the effects of Alexafluor photobleaching following five sequential images.  
 
Bio-molecular imaging 


































































Traditionally, the neuroimmune system has been studied by immunohistochemistry of key 
proteins and signalling molecules. In brief, immunohistochemistry (IHC; when using 
peroxidase reaction) or immunofluorescence (IF; when using fluorophores) enables 
visualization of target antigens within cells or tissue via antibodies labelled with peroxidases, 
biotin and/or fluorophores. This technique has been extensively used, and has furthered our 
understanding and appreciation of the topographical relationship between the different cell 
types and molecules within a defined region of tissue. IHC works well for thin tissue sections 
(5-50μm), as the light from the microscope remains relatively localized enabling discrete 
excitation of the fluorophore of interest. Imaging thicker sections of tissue (>50um to mm 
range), using conventional light microscopes and confocal scanning microscopes increases 
the scattering of light throughout the tissue, reducing the signal intensity and precise spatial 
localisation. To overcome this limitation, multiple slices of tissue are processed for IF and the 
images are digitally reconstructed, via image processing software, to generate a 3D image of 
the target. This process is time consuming, expensive and prone to artefacts due to difficulties 
in reconstructing images seamlessly.  
 
Novel deep tissue imaging methods 
Owing to the aforementioned constraints of IHC/IF, visualizing complex circuits from a 
systems perspective has historically been difficult. Many of the limitations, such as difficulty 
binding to and visualizing antigens, stem from the lipid membrane. The physical properties of 
the lipid bilayer prevents large macromolecules for example, antibodies, from readily 
diffusing deep into the tissue whilst the molecular heterogeneity of the lipids themselves alter 
the refractive index of the tissue, further perturbing the excitation and emission of light from 
fluorescently-labelled probes (Richardson & Lichtman 2015). To overcome these problems, 


































































3DISCO  have been developed (Susaki et al. 2015; Bin Yang et al. 2014; Renier et al. 2014; 
Tomer et al. 2014; Susaki et al. 2014; Ke et al. 2013; Becker et al. 2012; Hama et al. 2011). 
These methods make tissue optically transparent by removing the lipids and bringing the 
tissue to the same optical refractive index as the surrounding media. This enables light to 
penetrate deeper, facilitating the imaging of whole organs (Richardson & Lichtman 2015). 
Conventional IF protocols are subsequently applied to this tissue. However, for optimal 
staining the incubation time is significantly extended (hours and weeks in tissue slices and 
whole brains respectively) (Tomer et al. 2014) and the working distance of most microscope 
objectives limits the capture of whole organs. It is worth noting specialized lightsheet 
microscopes and CLARITY specific objectives can be employed to circumvent this 
limitation. However, these systems are expensive and consequently these may not be 
available to all researchers. 
 
Novel imaging compounds 
Nanoparticles 
Nanoparticles are specialized inorganic molecules that can be tailored to specific sizes. These 
particles can be doped with inorganic elements (impurities) within their crystal lattices to 
generate fluorescent signals (Lu et al. 2015). Much research has been devoted into methods 
that allow the coating and functionalization of nanoparticles with biomolecules such as 
antibodies to then allow visualization using widefield light and scanning confocal microscopy 
or with fibre optics. The main benefits of nanoparticles over traditional organic dyes and 
fluorophores include their enhanced luminescence signal, reduced background noise, superior 
stability, excitation ranges in the near infrared (NIR), and the ability to use time-resolved 
imaging. Time-resolved microscopy allows the collection of the fluorescence signal after a 


































































This removes the tissue autofluorescence from the signal of interest (Diamandis 1988). 
Interference from autofluorescence is a major issue in CNS tissues when imaging 
neuroinflammation due in part to high expression levels of endogenous amino acids and 
lipofuscins (Lakowicz 2006; Marmorstein et al. 2002). 
 
Among the different categories of nanoparticles, nanodiamonds, nano-rubies and lanthide-
based up conversion nanoparticles show great promise for future applications in in vitro 
microscopy  (see table 3). Nanoparticles have wide applicability including in vitro 
microscopy, small animal imaging, multimodal imaging, high sensitivity bio-sensing and 
photodynamic therapy (PDT) (Mochalin et al. 2012; Chatterjee et al. 2008). Although there 
have been recent advancements facilitating functionalization, due to the complexity of the 
surface functionalization methodology, the use of antibody-conjugated nanoparticles has yet 
to be fully exploited for bio-imaging (please see  Bradac et al. 2015; Lu et al. 2015; Edmonds 
& Sobhan 2013 for review)..  
Table 3 Characteristics of key nanoparticles with specific utility for bioimaging. 
 
An important next step in using these nanoparticles for bioimaging is refining the synthesis 
and surface modification strategies including the non-specific binding potential of the 
functional groups used for conjugation (mainly amino, carboxy and thiol; for details see  
Wang et al. 2011). By changing the overall charge of the particle, the functional groups can 
negatively impact colloidal stability and facilitate particle aggregation.  Fortunately the 
resulting particle aggregation can be resolved by chemically engineering suitable functional 
groups, such as polyethylene glycol, for bio-conjugation (Wang et al. 2011). Although an 
active area of research, the use of nanoparticles bio-conjugated to proteins, peptides or 


































































resolution of in vivo or in cleared CNS tissue. This will allow for greater imaging of low 
protein expression levels associated with central immune and neurokine signalling. 
 
Complementary RNA based probes 
RNA-based probes have contributed greatly to our understanding of RNA distribution 
throughout the brain. Visualization of RNA is achieved by hybridising complementary RNA 
sequences conjugated to fluorophores or other labelled molecules (RNA probes) to nucleic 
acids within tissue. There are a variety of molecular labels available for hybridisation 
including; hydrazine derivative of tetramethyl rhodamine isothiocyanate (TRITC); biotin-
tagged nucleic acids; and digoxigenin (DIG). A major advantage of both DIG-based in situ 
hybridisation (ISH) and fluorescent in situ hybridisation (FISH) is the possibility of 
simultaneously investigating multiple neuroinflammatory molecules with multiplexed 
fluorescent RNA probes, proteins and/or fluorescent tracer molecules in the brain and spinal 
cord (Parker et al. 2013; Jeong et al. 2010). 
 
Despite significant advances, as with IHC/IF, the current commercially available fluorescent 
conjugates used for FISH are not photostable for extended periods of time and can be 
difficult to differentiate from background autofluorescence in tissue samples. It is therefore 
essential to develop and utilise a new generation of highly sensitive, non-toxic and 
photostable nanoparticles for ISH-based imaging applications in brain and spinal cord tissues.  
 
As mentioned earlier, nanodiamonds are impervious to environmental changes and achieve 
visible fluorescence by exploiting intrinsic defects and impurities that are deep in a crystal 
lattice independent of their surface structure (Hui et al. 2010). This makes them ideal for 


































































tissue bleaching. Increased photostability is essential for improving neuroimaging capabilities 
of cleared brain tissues. Imaging whole organs require long exposure times owing to repeated 
z-stacking and are thus readily susceptible to bleaching with traditional fluorophore tagged 
probes or antibodies. Nanodiamonds are additionally non-toxic, emit beyond the range of 
cellular autofluorescence (with nitrogen or silicon vacancy centres) and have the ability to be 
utilised as efficient drug carriers (Merson et al. 2013) making them an ideal particle to 
incorporate into RNA based ISH techniques for whole organ imaging. Alternatively, the 
conjugation of improved fluorescent lanthanides such as the europium chelate BHHST (4,-4’-
bis-(1”,1”,1”,2”,2”,3”,3”-heptafluoro-4”,6”-hexanedion-6”-yl) sulfonylamino-propyl-ester-
N-succinimide-ester-o-terphenyl) to RNA probes would also be advantageous compared to 
conventional fluorophores. Lanthanide chelates including BHHST have greater signal 
detection sensitivity compared to traditional organic dyes and importantly also have the 
ability to discriminate against high levels of cellular background fluorescence for more 
accurate imaging confidence when used in association with time resolved microscopy 
(Connally et al. 2004).  
 
Novel imaging modalities 
MALDI imaging 
Mass spectrometry plays an important role in biomarker analysis due to its unique 
advantages, such as, high sensitivity, detection of a wide range of molecules, molecular 
specificity and multiplexed analysis on a single platform (Norris & Caprioli 2013a). Amid 
the various mass spectrometry ionisation techniques used to analyse tissues directly, Matrix 
Assisted Laser Desorption Ionization (MALDI) is the most widely used imaging mass 




































































Figure 2 MALDI imaging mass spectrometry. Schematic outline of a typical workflow for fresh frozen or 
formalin fixed formalin-fixed, paraffin-embedded tissue samples. The tissue section is mounted on a conductive 
(indium-tin oxide (ITO)) glass slide. Suitable matrix is applied across the tissue section and mass spectra are 
generated by a MALDI-time-of-flight (TOF) instrument. Ion (m/z value) densities of various molecules can be 
spatially displayed with their relative intensity in the tissue section. MALDI, matrix-assisted laser desorption 
ionization; MS, mass spectrometry; m/z, mass to charge ratio. 
 
Since its introduction in 1987 (Karas et al. 1987), MALDI-IMS has provided unique 
advantages in the analysis of tissue specimens. A broad spectrum of analytes ranging from 
proteins, peptides, glycans, lipids, small molecules, pharmaceutical compounds, endogenous 
and exogenous metabolites can be analysed in situ from tissue sections through this technique 
(Barry et al. 2015; Gustafsson et al. 2015; Patel et al. 2015; Quiason & Shahidi-Latham 2015; 
Uzbekova et al. 2015; Wang et al. 2015; Rebours et al. 2014; Touboul & Brunelle 2014; 
Zemski Berry et al. 2014). The data from such analysis is a pictograph that can be overlaid on 
the actual tissue sample; the location and intensity of the signal corresponds to the relative 
abundance of the analyte ions (Figure 2). Any tissue section could be used for such analysis, 
although typically these sections are covered with a suitable organic matrix material that co-
crystalizes with the sample molecules. A laser beam irradiation ablates the matrix surface 
with the formation of charged molecular species (Karas & Krüger 2003). These resulting ions 
traverse through a time-of-flight (TOF) analyser, and their mass-to-charge (m/z) is 
determined. Using different matrices and technology, several analyte classes can be identified 
(Norris & Caprioli 2013b). Typically a raster-scanned image of a tissue section provides a 
spatial resolution ranging from approximately 200 μm down to 20 μm generating a mass 
spectrum for every individual measuring spot (Aichler & Walch 2015). Recent technological 


































































compounds at a pixel size between 5 and 10 μm (Aichler & Walch 2015; Anderson et al. 
2014; Römpp & Spengler 2013; Römpp et al. 2011; Römpp et al. 2010).  
 
A pronounced advantage offered by this technique is the subsequent analysis by other 
traditional histological technologies of the same tissue section, for example, by haematoxylin 
and eosin (H & E) staining or IHC. The mass signals (m/z values) detected from MALDI-
IMS can be further visualised as ion intensity maps assigning molecular patterns to the tissue 
sections. The intensity of the unique m/z signals that correspond to the molecule of interest 
represents its distribution, localisation and relative abundance in the tissue section.
 
This 
visualization is similar to IHC however, it allows multiple molecules to be examined with 
one measurement. The multiplexed mapping of relevant biomolecules such as cytokines 
and neurotransmitters, can provide valuable knowledge and significant insights into 
neurobiology. For example, IMS enables the spatial quantification of numerous relevant 




Optical spectroscopy techniques offer a number of unique opportunities for in vitro and in 
vivo sensing applications. By using light to interrogate a sample, and seeking to correlate a 
change in the observed optical signal to a biological phenomenon, optical methods allow 
minimally-invasive measurements to be performed on sensitive samples. Different sensing 
modalities have been utilized for measurements of biologically relevant parameters, such as 
fluorescence sensing (Tsiminis et al. 2014), resonant techniques such as surface plasmon 


































































sensing or physical parameters (Warren-Smith & Monro 2014), or alternative label-free 
methods such as Raman spectroscopy (Movasaghi et al. 2007). 
 
Raman spectroscopy is particularly interesting for biomedical sensing, as it is a label-free 
technique that can uniquely identify chemical species present in a sample. Raman 
spectroscopy is a form of vibrational spectroscopy that uses excitation from a monochromatic 
laser light to interrogate samples by analysing the shift in energy of a small part of these 
excitation photons due to interactions between the excitation light and the vibrational modes 
of the chemical bonds in the molecule (Ferraro et al. 2002). Specifically, the laser light sets 
the bonds’ vibrational modes in motion, producing light at certain optical frequencies; much 
like hitting a tuning fork with a small rod sets vibrations in motion with specific frequencies 
in the audible spectrum, Raman spectroscopy produces a vibrational spectral signature that 
can be used to determine the chemical composition and therefore the type of analyte present 
in a sample (Carey 1978). This is illustrated in in Figure 3 for the simple case of hydrogen 
peroxide (H2O2).  
 
Figure 3 Simulated Raman spectrum of hydrogen peroxide (H2O2), showing the different peaks corresponding 
to the vibrational modes of the chemical bonds in the molecule. 
 
Since this method does not require labelling of the targets before measuring it has the 
potential to allow for in vivo analysis of biological samples (Freudiger et al. 2008; Vo-Dinh 
et al. 2005) and has found applications in brain lipid identification (Krafft et al. 2005). 
 
A historical limitation of Raman spectroscopy is the low signal intensities observed due to 
the weak nature of the interactions involved. This results in optical signals that are 


































































such as surface enhanced Raman spectroscopy (SERS) (Le Ru & Etchegoin 2009), or 
coherent anti-Stokes Raman spectroscopy (CARS) (Begley 1974) can mitigate this issue, 
resulting in renewed interest in Raman spectroscopy for sensitive detection in biology and 
medicine (Hanlon et al. 2000). CARS in particular has found widespread adoption when it 
comes to tissue imaging as it enables the mapping of specific chemical species in 2 or 3 
dimensions in tissue samples (Evans & Xie 2008). 
 
In addition to the measurements of biomarkers and chemical species on samples, Raman 
spectroscopy has also found extensive use for in vivo applications (Romeike et al. 2015). 
Typically, Raman spectroscopy is used to identify different chemicals, such as lipids (Nan et 
al. 2003), proteins (Uzunbajakava et al. 2003) and myelin (Wang et al. 2005), found in tissue. 
Changes in these parameters can be linked to histopathological observations, for example the 
identification of metastatic brain cancer (Fullwood et al. 2014). Raman spectroscopy and 
imaging has, through its ability to identify subtle changes in tissue composition, found 
applications in the fields of early-stage inflammatory apoptosis of adult hippocampal stem 
cells (Ladiwala et al. 2014), cancer identification in human brain tissue (Jermyn et al. 2015; 
Ji et al. 2013) and changes in blood vessels associated with heart disease (Matthaus et al. 
2012). 
 
Concluding remarks: future of ‘neuroinflammation’ imaging  
Neuroinflammation is a dynamic and complex process involving many cell types and 
macromolecules. Current techniques employed to visualise these processes are insufficient 
due to major limitations in their temporal and spatial resolution. These issues are 
compounded by the inherent complexities associated with antibody use but can be aided by 


































































potential of novel bio-imaging molecules, for example, nanoparticles, which can be 
incorporated into existing methods to circumvent problems associated with traditional 
fluorophores. Given that nanoparticles do not photobleach and provide discreet signals, it is 
logical to apply these technologies to cleared tissue. By combining these two techniques we 
will be able to clearly view deep brain regions that will, undoubtedly, enhance our 
understanding of this elaborate system in diseased and non-diseased states. 
 
Collaboration is key, and by adopting a transdisciplinary approach, technologies readily 
available to researchers in the proteomics and physics disciplines can be incorporated or 
adapted to develop label-free methods for elucidating sample composition. MALDI, for 
example, is a very powerful method for identifying the protein, lipid or small molecule 
composition of tissues or even whole organs. Importantly, this information can be retrieved 
and analysed with respect to spatial and potentially temporal resolution, something that is 
currently not possible with traditional imaging methods. Raman spectroscopy is another such 
example where the chemical composition of a sample can be identified without the need for 
exogenous labels. Such label-free technologies will prove to be very powerful for addressing 
major challenges in the imaging field, such as the imaging of neuroinflammation in real-time 
in live animals.  
 
The technologies discussed in this review have the potential to enhance our understanding of 
the neuroimmune system and facilitate the advent of new diagnostic tests and potential 
treatment targets. This is particularly relevant for humans given that our current attempts to 
image neuroinflammation in real time is substantially hampered by our lack of 
“neuroinflammatory” markers. For example, there has been an over reliance of using 


































































of neuroinflammation in PET scans. Unfortunately, the reproducibility and reliability of these 
markers is often questioned, thereby limiting our understanding and insight of human 
neuroinflammatory diseases (Stefaniak & O'Brien 2015). By using novel techniques such as 
Raman or MALDI, we aim to include functionally informative measurements that will 
translate to more accurate imaging and identify potential therapeutic targets of 
neuroinflammation-associated pathologies. The combination of established and emerging 
techniques across different scientific fields will no doubt aid in the prognosis and treatment 
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T Cells CD4, CD8. FOXP3, IL-17. Adaptive immune 




Oligodendrocytes MOG. MBE. Ensheath CNS 
neurons in myelin 




CD, cluster of differentiation; ChAT, choline acetyltransferase; EAAT, excitatory amino acid transporters; 
FOXP3, forkhead box P3; GFAP, glial fibrillary acidic protein, GLAST-1, glutamate aspartate transporter-1; 
GLT, L-glutamate transporter-1; Iba-1, ionized calcium binding adapter molecule-1; IL, interleukin; MAP2, 
microtubule-associated protein 2; MBP, myelin basic protein; MOG, myelin-oligodendrocyte glycoprotein; 
NeuN, neuronal nuclei or feminizing locus on X-3; nNOS, neuronal nitric oxide synthase; NSE, neuron specific 
enolase; VCAM-1, vascular cell adhesion protein; ZO-1, zona occuldens-1. 
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ATP, adenosine triphosphate; CCL2, chemokine (C-C motif) ligand 2; HMGB1, high-mobility group box 1; IL-
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